Life Science Vision (LSV) Capital
Status
ACTIVE
Global HQ
London, United Kingdom
Countries of investment
- United Kingdom
Investment stages
- Seed
Industries
- Pharma
- Biotechnology
- Medical Devices
- Digital Health
About
Life Science Vision (LSV) Capital Partners is a premier global investment firm dedicated to advancing the fields of life sciences and digital healthcare. By strategically investing in groundbreaking innovations across medical technology, digital health, and biopharmaceuticals, LSV Capital Partners is committed to transforming healthcare delivery and enhancing patient outcomes on a global scale. Their extensive expertise and network enable them to identify and support visionary entrepreneurs and pioneering companies that are poised to redefine the future of healthcare. LSV Capital Partners strives to create lasting impact through innovation, collaboration, and a relentless focus on improving the well-being of individuals around the world.
Life Science Vision (LSV) Capital Partners is a premier global investment firm dedicated to advancing the fields of life sciences and digital healthcare. By strategically investing in groundbreaking innovations across medical technology, digital health, and biopharmaceuticals, LSV Capital Partners is committed to transforming healthcare delivery and enhancing patient outcomes on a global scale. Their extensive expertise and network enable them to identify and support visionary entrepreneurs and pioneering companies that are poised to redefine the future of healthcare. LSV Capital Partners strives to create lasting impact through innovation, collaboration, and a relentless focus on improving the well-being of individuals around the world.
Investment Thesis
Life Science Vision Capital seeks to invest in innovative healthcare and life sciences companies. Their focus is on early stage startups that are developing breakthrough technologies in biotechnology, medical devices, and pharmaceuticals.
Manager's Experience
With extensive experience in venture capital, the fund manager has actively engaged in over 100 deals, primarily in the technology and healthcare sectors across North America and Europe. Their operator-first approach emphasizes hands-on support for portfolio companies, facilitating notable exits that have consistently generated strong returns. Focusing on early to growth-stage investments, they strategically leverage data-driven insights to identify and capitalize on emerging market trends. This dynamic investment style has built a robust portfolio that showcases their ability to drive value and foster innovation.
Team
Steve Jacobs
Shu Joshi
Levi Shapiro